ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,448,750 | -13.7% | 53,917 | +14.5% | 0.08% | -11.1% |
| Q2 2023 | $1,679,122 | +25.2% | 47,087 | -10.8% | 0.09% | +8.4% |
| Q1 2023 | $1,341,171 | +83.7% | 52,802 | +193.4% | 0.08% | +76.6% |
| Q4 2022 | $730,039 | +26.3% | 17,999 | +3.0% | 0.05% | +11.9% |
| Q3 2022 | $578,000 | -7.7% | 17,476 | -1.8% | 0.04% | +5.0% |
| Q2 2022 | $626,000 | -33.1% | 17,792 | -12.6% | 0.04% | +2.6% |
| Q1 2022 | $936,000 | -37.0% | 20,359 | -9.2% | 0.04% | -20.4% |
| Q4 2021 | $1,486,000 | -4.4% | 22,412 | -10.0% | 0.05% | -5.8% |
| Q3 2021 | $1,554,000 | +121.4% | 24,899 | +193.7% | 0.05% | +116.7% |
| Q2 2021 | $702,000 | +21.5% | 8,479 | -2.8% | 0.02% | +9.1% |
| Q1 2021 | $578,000 | -23.8% | 8,720 | -11.9% | 0.02% | -33.3% |
| Q4 2020 | $759,000 | +90.2% | 9,893 | +6.8% | 0.03% | +57.1% |
| Q3 2020 | $399,000 | +56.5% | 9,266 | +56.8% | 0.02% | +50.0% |
| Q2 2020 | $255,000 | -57.7% | 5,909 | -37.9% | 0.01% | -46.2% |
| Q4 2019 | $603,000 | +123.3% | 9,514 | -0.6% | 0.03% | +85.7% |
| Q3 2019 | $270,000 | +9.8% | 9,568 | +3.0% | 0.01% | +16.7% |
| Q2 2019 | $246,000 | – | 9,290 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |